ACTUATE THERAPEUTICS, INC. (ACTU) · INSIDERData sourcesSEC Form 410m ago
House PTR9m ago
SEC 13F9m ago
Robinhood Chain9m ago
Public companyACTUATE THERAPEUTICS, INC.
ACTUCIK 0001652935
Price$0.33
1 year-94.9%
Disclosed transactions31
Buys / sells2 / 0
Max Insider Score41
Connections with evidence16
ACTU · disclosed activity on price
| Score | Actor | Security | Side | Value | Executed | Disclosed | Lag | Source | Evidence |
|---|
| 9 | BFBIOS Fund III, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 126.2K sh | Oct 28, 2026 | Oct 30, 2026 |
- Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
- BIOS Fund III QP, LPDirector, 10% Owner · Oct 30, 2026
- BIOS Fund III NT, LPDirector, 10% Owner · Oct 30, 2026
- BIOS Fund I, LPDirector, 10% Owner · Oct 30, 2026
| 9 | BIBIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 65.0K sh | Oct 28, 2026 | Oct 30, 2026 traded Oct 28, 2026 | +2d | SEC Form 4 | |
| 9 | BIBIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 36.1K sh | Oct 28, 2026 | Oct 30, 2026 traded Oct 28, 2026 | +2d | SEC Form 4 | |
| 9 | BIBIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 269.3K sh | Oct 28, 2026 | Oct 30, 2026 traded Oct 28, 2026 | +2d | SEC Form 4 | |
| 9 | BIBIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 82.5K sh | Oct 28, 2026 | Oct 30, 2026 traded Oct 28, 2026 | +2d | SEC Form 4 | |
| 9 | BIBIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 133.1K sh | Oct 28, 2026 | Oct 30, 2026 traded Oct 28, 2026 | +2d | SEC Form 4 | |
| 9 | BFBIOS Fund III, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 82.5K sh | Oct 28, 2026 | Oct 30, 2026 traded Oct 28, 2026 | +2d | SEC Form 4 | |
| 9 | BFBIOS Fund III, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 133.1K sh | Oct 28, 2026 | Oct 30, 2026 traded Oct 28, 2026 | +2d | SEC Form 4 | |
| 9 | BFBIOS Fund III, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 824.0K sh | Oct 28, 2026 | Oct 30, 2026 traded Oct 28, 2026 | +2d | SEC Form 4 | |
| 9 | BFBIOS Fund III, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 269.3K sh | Oct 28, 2026 | Oct 30, 2026 traded Oct 28, 2026 | +2d | SEC Form 4 | |
| 9 | BIBIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 48.0K sh | Oct 28, 2026 | Oct 30, 2026 traded Oct 28, 2026 | +2d | SEC Form 4 | |
| 9 | BIBIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 87.7K sh | Oct 28, 2026 | Oct 30, 2026 traded Oct 28, 2026 | +2d | SEC Form 4 | |
| 9 | BIBIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 368.3K sh | Oct 28, 2026 | Oct 30, 2026 traded Oct 28, 2026 | +2d | SEC Form 4 | |
| 9 | BIBIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 195.0K sh | Oct 28, 2026 | Oct 30, 2026 traded Oct 28, 2026 | +2d | SEC Form 4 | |
| 9 | BFBIOS Fund III, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 36.1K sh | Oct 28, 2026 | Oct 30, 2026 traded Oct 28, 2026 | +2d | SEC Form 4 | |
| 9 | BFBIOS Fund III, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 368.3K sh | Oct 28, 2026 | Oct 30, 2026 traded Oct 28, 2026 | +2d | SEC Form 4 | |
| 9 | BIBIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 126.2K sh | Oct 28, 2026 | Oct 30, 2026 traded Oct 28, 2026 | +2d | SEC Form 4 | |
| 9 | BFBIOS Fund III, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 65.0K sh | Oct 28, 2026 | Oct 30, 2026 traded Oct 28, 2026 | +2d | SEC Form 4 | |
| 9 | BFBIOS Fund III, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 82.0K sh | Oct 28, 2026 | Oct 30, 2026 traded Oct 28, 2026 | +2d | SEC Form 4 | |
| 9 | BFBIOS Fund III, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 195.0K sh | Oct 28, 2026 | Oct 30, 2026 traded Oct 28, 2026 | +2d | SEC Form 4 | |
| 9 | BIBIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 824.0K sh | Oct 28, 2026 | Oct 30, 2026 traded Oct 28, 2026 | +2d | SEC Form 4 | |
| 9 | BIBIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 682.9K sh | Oct 28, 2026 | Oct 30, 2026 traded Oct 28, 2026 | +2d | SEC Form 4 | |
| 9 | BIBIOS Fund I, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 82.0K sh | Oct 28, 2026 | Oct 30, 2026 traded Oct 28, 2026 | +2d | SEC Form 4 | |
| 9 | BFBIOS Fund III, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 87.7K sh | Oct 28, 2026 | Oct 30, 2026 traded Oct 28, 2026 | +2d | SEC Form 4 | |
| 9 | BFBIOS Fund III, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 682.9K sh | Oct 28, 2026 | Oct 30, 2026 traded Oct 28, 2026 | +2d | SEC Form 4 | |
| 9 | BFBIOS Fund III, LPDirector, 10% Owner | ACTUACTUATE THERAPEUTICS, INC. Grant or award | A | — 48.0K sh | Oct 28, 2026 | Oct 30, 2026 traded Oct 28, 2026 | +2d | SEC Form 4 | |
| 37 | SMSchmitt Daniel MDirector, President, CEO and Director | ACTUACTUATE THERAPEUTICS, INC. Open-market purchase | BUY | $50K 140.8K sh | Oct 28, 2026 | Oct 29, 2026 traded Oct 28, 2026 | +1d | SEC Form 4 | |
| 41 | SMSchmitt Daniel MDirector, President, CEO and Director | ACTUACTUATE THERAPEUTICS, INC. Open-market purchase | BUY | — 70.4K sh | Oct 28, 2026 | Oct 29, 2026 traded Oct 28, 2026 | +1d | SEC Form 4 | |
| 21 | SMSchmitt Daniel MDirector, President, CEO and Director | ACTUACTUATE THERAPEUTICS, INC. Option exercise | M | — 272.1K sh | Aug 14, 2026 | Aug 14, 2026 traded Aug 14, 2026 | +0d | SEC Form 4 | |
| 24 | SMSchmitt Daniel MDirector, President, CEO and Director | ACTUACTUATE THERAPEUTICS, INC. Tax withholding | F | $122K 120.5K sh | Aug 14, 2026 | Aug 14, 2026 traded Aug 14, 2026 | +0d | SEC Form 4 | |
| 9 | SMSchmitt Daniel MDirector, President, CEO and Director | ACTUACTUATE THERAPEUTICS, INC. Option exercise | M | — 272.1K sh | Aug 14, 2026 | Aug 14, 2026 traded Aug 14, 2026 | +0d | SEC Form 4 | |
Director, 10% Owner · Oct 30, 2026
Planned sales and 5% stakes
Form 144, 13D and 13G